Bio-Techne's CEO to Speak at 2026 Global Healthcare Conference by Bank of America
On May 12, 2026, Bio-Techne Corporation's President and CEO, Kim Kelderman, will take center stage at the Bank of America Securities 2026 Global Healthcare Conference, scheduled to begin at 9:20 a.m. PDT. The presentation will be accessible live through Bio-Techne’s Investor Relations website, specifically on the IR Calendar page.
Established 50 years ago, Bio-Techne Corporation (NASDAQ: TECH) is a leader in the life sciences sector, providing crucial tools and resources that empower researchers and diagnostic professionals. The company has built a reputation for excellence by offering high-quality reagents, analytical instruments, and precision diagnostics tailored to various scientific needs. Their comprehensive product portfolio includes over 500,000 products utilized by academic researchers, biopharmaceutical firms, and clinical diagnostic laboratories worldwide.
Bio-Techne operates under three main brands—RD Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™—each reflecting different phases of the scientific journey, ranging from discovery and translational research to clinical decision-making. The company, headquartered in Minnesota, has established a global presence with operations in 34 locations and a workforce of approximately 3,100 employees. Notably, in the fiscal year 2025, Bio-Techne reported remarkable financial results, generating over $1.2 billion in net sales.
The upcoming presentation at the Bank of America conference represents an excellent opportunity for both the company and its stakeholders. Through this platform, Kim Kelderman is expected to share insights about Bio-Techne's strategic direction, technological advancements, and future innovations that will undoubtedly impact the healthcare landscape. Attendees will gain valuable perspectives on how Bio-Techne continues to lead in providing essential life science tools and services.
In addition to the live presentation, those interested can find further details about Bio-Techne’s extensive range of products and solutions on their official website at www.bio-techne.com. The company also shares updates and information on various social media platforms, including LinkedIn, X, and YouTube, allowing stakeholders and the general public to stay informed on the latest developments and innovations.
As the event draws nearer, anticipation is building within the industry, where innovations and advancements in healthcare are continuously evolving. Bio-Techne is poised to showcase its commitment to enhancing scientific outcomes through its high-caliber products and services at this critical event in the global healthcare arena.
Established 50 years ago, Bio-Techne Corporation (NASDAQ: TECH) is a leader in the life sciences sector, providing crucial tools and resources that empower researchers and diagnostic professionals. The company has built a reputation for excellence by offering high-quality reagents, analytical instruments, and precision diagnostics tailored to various scientific needs. Their comprehensive product portfolio includes over 500,000 products utilized by academic researchers, biopharmaceutical firms, and clinical diagnostic laboratories worldwide.
Bio-Techne operates under three main brands—RD Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™—each reflecting different phases of the scientific journey, ranging from discovery and translational research to clinical decision-making. The company, headquartered in Minnesota, has established a global presence with operations in 34 locations and a workforce of approximately 3,100 employees. Notably, in the fiscal year 2025, Bio-Techne reported remarkable financial results, generating over $1.2 billion in net sales.
The upcoming presentation at the Bank of America conference represents an excellent opportunity for both the company and its stakeholders. Through this platform, Kim Kelderman is expected to share insights about Bio-Techne's strategic direction, technological advancements, and future innovations that will undoubtedly impact the healthcare landscape. Attendees will gain valuable perspectives on how Bio-Techne continues to lead in providing essential life science tools and services.
In addition to the live presentation, those interested can find further details about Bio-Techne’s extensive range of products and solutions on their official website at www.bio-techne.com. The company also shares updates and information on various social media platforms, including LinkedIn, X, and YouTube, allowing stakeholders and the general public to stay informed on the latest developments and innovations.
As the event draws nearer, anticipation is building within the industry, where innovations and advancements in healthcare are continuously evolving. Bio-Techne is poised to showcase its commitment to enhancing scientific outcomes through its high-caliber products and services at this critical event in the global healthcare arena.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.